IRIS Accounts Production v25.2.0.378 NI642755 Board of Directors Board of Directors 1.1.24 31.12.24 31.12.24 17/9/25 false true false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhNI6427552023-12-31NI6427552024-12-31NI6427552024-01-012024-12-31NI6427552022-12-31NI6427552023-01-012023-12-31NI6427552023-12-31NI642755ns15:NorthernIreland2024-01-012024-12-31NI642755ns14:PoundSterling2024-01-012024-12-31NI642755ns10:Director12024-01-012024-12-31NI642755ns10:Director22024-01-012024-12-31NI642755ns10:PrivateLimitedCompanyLtd2024-01-012024-12-31NI642755ns10:SmallEntities2024-01-012024-12-31NI642755ns10:Audited2024-01-012024-12-31NI642755ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-31NI642755ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-31NI642755ns10:FullAccounts2024-01-012024-12-31NI642755ns10:CompanySecretary12024-01-012024-12-31NI642755ns10:RegisteredOffice2024-01-012024-12-31NI642755ns5:CurrentFinancialInstruments2024-12-31NI642755ns5:CurrentFinancialInstruments2023-12-31NI642755ns5:ShareCapital2024-12-31NI642755ns5:ShareCapital2023-12-31NI642755ns5:SharePremium2024-12-31NI642755ns5:SharePremium2023-12-31NI642755ns5:RetainedEarningsAccumulatedLosses2024-12-31NI642755ns5:RetainedEarningsAccumulatedLosses2023-12-31NI642755ns5:PlantMachinery2024-01-012024-12-31NI642755ns5:PlantMachinery2023-12-31NI642755ns5:PlantMachinery2024-12-31NI642755ns5:PlantMachinery2023-12-31NI642755ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-31NI642755ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-31
REGISTERED NUMBER: NI642755 (Northern Ireland)















Financial Statements for the Year Ended 31 December 2024

for

Biorex Food Diagnostics Limited

Biorex Food Diagnostics Limited (Registered number: NI642755)






Contents of the Financial Statements
for the year ended 31 December 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Biorex Food Diagnostics Limited

Company Information
for the year ended 31 December 2024







DIRECTORS: Dr M Afrasiabi
Dr Z Zolnourian



SECRETARY: Dr Z Zolnourian



REGISTERED OFFICE: 9a The Technology Park
Antrim
BT41 1QS



REGISTERED NUMBER: NI642755 (Northern Ireland)



AUDITORS: Cleaver Black
Chartered Accountants
Registered Auditors
Suite 5 Ormeau House
91-97 Ormeau Road
Belfast
Co. Antrim
BT7 1SH



BANKERS: Danske Bank
1-2 Broadway
Ballymena
BT43 7AA



SOLICITORS: Conway Todd & Co
Mirtna Buildings
22 Market Square
Antrim
BT41 4DT

Biorex Food Diagnostics Limited (Registered number: NI642755)

Balance Sheet
31 December 2024

2024 2023
Notes £    £   
FIXED ASSETS
Tangible assets 4 - 9,287

CURRENT ASSETS
Stocks 5 65,426 28,070
Debtors 6 164,111 9,751
Cash at bank 75,471 142,536
305,008 180,357
CREDITORS
Amounts falling due within one year 7 (688,571 ) (391,981 )
NET CURRENT LIABILITIES (383,563 ) (211,624 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(383,563

)

(202,337

)

CAPITAL AND RESERVES
Called up share capital 1 1
Share premium 43,477 43,477
Retained earnings (427,041 ) (245,815 )
(383,563 ) (202,337 )

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17 September 2025 and were signed on its behalf by:




Dr M Afrasiabi - Director



Dr Z Zolnourian - Director


Biorex Food Diagnostics Limited (Registered number: NI642755)

Notes to the Financial Statements
for the year ended 31 December 2024

1. STATUTORY INFORMATION

Biorex Food Diagnostics Limited is a private company, limited by shares , registered in Northern Ireland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries of Fortress Group Holdings Ltd..

Revenue
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the
Company and the revenue can be reliably measured. Revenue is measured as the fair value of the
consideration received or receivable, excluding discounts, rebates, value added tax and other sales
taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:

1The Company has transferred the significant risks and rewards of ownership to the buyer;

2
The Company retains neither continuing managerial involvement to the degree usuallyassociated with
ownership nor effective control over the goods sold;
3The amount of revenue can be measured reliably;
4It is probable that the Company will receive the consideration due under the transaction; and
5The costs incurred or to be incurred in respect of the transaction can be measured reliably.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 15% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Biorex Food Diagnostics Limited (Registered number: NI642755)

Notes to the Financial Statements - continued
for the year ended 31 December 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Going concern
The directors of Biorex Food Diagnostics Limited have reviewed the resources available, both at a
company level and as part of the wider Fortress Group. The directors believe that the company and
group have adequate resources to continue in operational existence for the foreseeable future.

Accordingly, Biorex Food Diagnostics Limited continue to adopt the going concern basis in
preparing the financial statements.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
£   
COST
At 1 January 2024
and 31 December 2024 115,598
DEPRECIATION
At 1 January 2024 106,311
Charge for year 9,287
At 31 December 2024 115,598
NET BOOK VALUE
At 31 December 2024 -
At 31 December 2023 9,287

5. STOCKS
2024 2023
£    £   
Finished goods 65,426 28,070

Biorex Food Diagnostics Limited (Registered number: NI642755)

Notes to the Financial Statements - continued
for the year ended 31 December 2024

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 10,431 9,751
Amounts owed by group undertakings 153,513 -
Other debtors 167 -
164,111 9,751

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Amounts owed to group undertakings 622,132 391,510
VAT 371 371
Other creditors - 100
Accruals 66,068 -
688,571 391,981

8. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Anthony Bradley FCA (Senior Statutory Auditor)
for and on behalf of Cleaver Black

9. ULTIMATE PARENT UNDERTAKING

During the year the company continued to be a wholly owned subsidiary of Fortress Group Holdings Limited, a company incorporated in Northern Ireland.